Sfoglia per Autore
Functional studies on sIL-2R release by Sezary cells
1992-01-01 Appino A; Fierro mT; Novelli M; Lisa F; Bernengo MG
Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study
1992-01-01 FIERRO MT; LISA F; M. NOVELLI; BERTERO M; BERNENGO MG
Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.
1993-01-01 BERNENGO MG; FIERRO MT; NOVELLI M; LISA F; APPINO A
Molecole di adesione nella granulomatosi linfomatoide.
1993-01-01 Bertero M; Savoia P; Novelli M:
Linfoma pleomorfo a cellule T con manifestazioni bollose.
1993-01-01 Savoia P; Novelli M; Bertero M
Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
1993-01-01 M.T. FIERRO; M. BERTERO; M. NOVELLI; A. APPINO; G.C. DOVEIL; S. COLONNA; M.G. BERNENGO
Prognostic factors in Sézary syndrome.
1994-01-01 Bernengo MG; Novelli M; Appino A; Quaglino P; Savoia P; Fierro MT
Linfomi cutanei (non micosi fungoide) a cellule T CD30-
1994-01-01 BERNENGO M.G.; NOVELLI M; QUAGLINO P.
Mantle zone lymphoma: an immunohistologic study of skin lesions.
1994-01-01 M. BERTERO; M. NOVELLI; M.T. FIERRO; M.G. BERNENGO
Adhesion molecules in lymphomatoid granulomatosis
1994-01-01 SAVOIA P; M. NOVELLI; BERTERO M; BERNENGO MG
La sindrome di Sézary.
1994-01-01 BERNENGO M.G.; NOVELLI M; QUAGLINO P; FIERRO MT.
Linfomi cutanei: sopravvivenza di 429 pazienti sulla base di parametri istologici e immunoistochimici.
1994-01-01 Doveil GC; Novelli M; Lisa F; Savoia P; Bertero M; Bernengo MG:
CD26 (DPP-IV)- A useful marker in Sezary sindrome
1994-01-01 Novelli M; Fierro MT; Quaglino P; Lisa F; Doveil GC; Bernengo MG
Cutaneous lymphomas: survival according to histological and immunological features in 429 patients.
1994-01-01 Bernengo MG; Novelli M; Lisa F; Savoia P; Doveil GC; Bertero M
Thymopentin in Sezary syndrome. Clinical and immunological effects.
1994-01-01 BERNENGO MG; APPINO A; NOVELLI M.
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS).
1995-01-01 Novelli M; Quaglino P; Fierro MT; Savoia P; De Matteis A; Bernengo MG
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL).
1995-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
CD4+CD26- evaluation is a more useful diagnostic parameter than CD4+CD7- in Sézary syndrome (SS).
1995-01-01 Novelli M; Quaglino P; Fierro MT; Savoia P; De Matteis A; Bernengo MG
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance
1995-01-01 DOVEIL GC; FIERRO MT; M. NOVELLI; APPINO A; BERTERO M; QUAGLINO P; BERNENGO MG
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL).
1995-01-01 Savoia P; Fierro MT; Novelli M; Verrone A; Quaglino P; Bernengo MG
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile